Silke B, Verma S P, Nelson G I, Ahuja R C, Hussain M, Taylor S H
Br J Clin Pharmacol. 1984 Jun;17(6):735-43. doi: 10.1111/j.1365-2125.1984.tb02411.x.
The differences between slow calcium blocking agents with respect to effects on heart rate, myocardial contractility and atrioventricular conducting time are well described; the relevance of such differences to the treatment of patients with impaired left ventricular function due to coronary heart disease is uncertain. The haemodynamic effects of equivalent hypotensive doses of nifedipine and verapamil were therefore compared in 20 patients with severe angina pectoris associated with angiographically documented coronary artery disease. The plasma concentrations of nifedipine (mean 57 +/- 19; range 27-77 ng/ml) and verapamil (mean 147 +/- 14; range 117-260 ng/ml) at the time of the haemodynamic measurements were of an order usually associated with substantial pharmacodynamic activity. Sitting at rest nifedipine resulted in reduction in systemic arterial pressure (P less than 0.05) and vascular resistance (P less than 0.01); both the heart rate (P less than 0.01) and cardiac output (P less than 0.05) increased without any significant change in the left heart filling pressure. In contrast, verapamil, which similarly reduced systemic blood pressure (P less than 0.05) and vascular resistance (P less than 0.01), increased cardiac output (P less than 0.05) and left heart filling pressure (P less than 0.05) without any change in heart rate. During upright bicycle exercise both drugs attenuated the angina induced in all subjects during the control exercise period. Despite reductions in systemic blood pressure and vascular resistance the cardiac output was unaltered on either drug at the same workload as in the control assessment. The reduction in exercise blood pressure following nifedipine induced a reflex tachycardia; this was not present, despite the similar hypotensive action, after verapamil.(ABSTRACT TRUNCATED AT 250 WORDS)
关于慢钙阻滞剂对心率、心肌收缩力和房室传导时间的影响,已有详尽描述;但这些差异与冠心病所致左心室功能受损患者治疗的相关性尚不确定。因此,对20例伴有血管造影证实的冠状动脉疾病的严重心绞痛患者,比较了等效降压剂量硝苯地平和维拉帕米的血流动力学效应。血流动力学测量时,硝苯地平的血浆浓度(平均57±19;范围27 - 77纳克/毫升)和维拉帕米的血浆浓度(平均147±14;范围117 - 260纳克/毫升)处于通常与显著药效学活性相关的水平。静息坐位时,硝苯地平使体动脉压降低(P<0.05)和血管阻力降低(P<0.01);心率(P<0.01)和心输出量增加(P<0.05),而左心充盈压无显著变化。相比之下,维拉帕米同样降低体循环血压(P<0.05)和血管阻力(P<0.01),增加心输出量(P<0.05)和左心充盈压(P<0.05),心率无变化。在直立自行车运动期间,两种药物均减轻了所有受试者在对照运动期诱发的心绞痛。尽管体循环血压和血管阻力降低,但在与对照评估相同的工作量下,两种药物对心输出量均无影响。硝苯地平使运动血压降低后诱发反射性心动过速;尽管维拉帕米有类似的降压作用,但未出现这种情况。(摘要截选至250字)